Official Title
Management of Diabetic Patients With Telemedicine in the Context of the Covid-19 Epidemic: Prospective Observational Study
Brief Summary

Since the end of February 2020, Covid-19 infection has spread widely in France, particularly in the East region, with on March 25th, 2020, 5,479 infected patients and 407 deceased patients, including 256 in Alsace. Among the hospitalized patients reported in the initial Chinese studies, 48% had co-morbidity, particularly diabetes or cardiovascular disease. Covid-19 infection does not appear to be more common in diabetic patients, but infected diabetics have more severe forms. The prevalence of diabetes is high in Alsace affecting 6.5% of the population against 4.6% in France. Du to health containment measures, asymptomatic diabetic patients can no longer come to the clinic in Hospital for their consultation. However, in the current epidemiological context, maintaining optimal glycemic control is fundamental since some of diabetic patients will have Covid-19 infections. Furthermore, the sedentary lifestyle and snacking linked to the confinement period will contribute to a glycemic imbalance in some patients. Telemedicine, and in particular teleconsultation, which until now has been very uncommon in the management of diabetic patients, represents a very interesting alternative for monitoring these patients and maintaining satisfactory metabolic control during the current period of confinement and Covid-19 epidemic.

Completed
Diabetes
COVID-19

Other: care modalities

For these patients the consultation has been postponed for 6 months. No specific intervention for this group of patient.

Other: Teleconsultation either by phone or by computer consultation

Management of diabetic patients by telemedicine with a teleconsultation either by phone or by computer consultation

Eligibility Criteria

Inclusion Criteria:

- Adult diabetic patient (type 1,2, MODY, secondary, post transplantation) followed by
diabetology consultation at the hospital or by a liberal diabetologist

- Subject affiliated to a social health insurance

- Subject able to understand the objectives of the research

- Subject who expressed his non opposition to the research

Exclusion Criteria:

- Pregnant woman

- Patients with acute complications (foot ulcer, post stroke, post IDM)

- Cancer or life expectancy of less than 6 months

- Inability to provide informed information to the subject (subject in an emergency,
difficulty of understanding for the subject, etc.)

- Subject under judicial protection

- Subject under guardianship or curatorship

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
France
Locations

Hôpitaux Universitaires de Strasbourg
Strasbourg, France

University Hospital, Strasbourg, France
NCT Number
Keywords
Diabetes
telemedicine
Covid-19 epidemic
Glucose control
MeSH Terms
COVID-19